Trial Outcomes & Findings for Acute Comfort of Lubricant Eye Drop FID 111421 (NCT NCT00673959)

NCT ID: NCT00673959

Last Updated: 2012-02-02

Results Overview

Drop comfort grading scale is a scale from 0 to 9, with 0 meaning most comfortable and 9 meaning most uncomfortable.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

20 participants

Primary outcome timeframe

upon instillation

Results posted on

2012-02-02

Participant Flow

20 Dry Eye Subjects

Randomized, double-masked, crossover

Participant milestones

Participant milestones
Measure
Lubricant Drops, Then Optive Drops
Patients received Lubricant Drops first, then received Optive Drops
Optive Drops, Then Lubricant Drops
Patients received Optive Drops first, then received Lubricant Drops
Overall Study
STARTED
10
10
Overall Study
COMPLETED
10
10
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Acute Comfort of Lubricant Eye Drop FID 111421

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Overall Study
n=20 Participants
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
17 Participants
n=5 Participants
Age, Categorical
>=65 years
3 Participants
n=5 Participants
Sex: Female, Male
Female
16 Participants
n=5 Participants
Sex: Female, Male
Male
4 Participants
n=5 Participants

PRIMARY outcome

Timeframe: upon instillation

Drop comfort grading scale is a scale from 0 to 9, with 0 meaning most comfortable and 9 meaning most uncomfortable.

Outcome measures

Outcome measures
Measure
Lubricant Eye Drop FID 111421
n=20 Participants
Optive Lubricant Eye Drop
n=20 Participants
Drop Comfort Upon Instillation
1.7 Units on a scale
Standard Deviation 1.8
1.3 Units on a scale
Standard Deviation 1.4

Adverse Events

Lubricant Eye Drop FID 111421

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Optive Lubricant Eye Drop

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Alcon Clinical

Alcon Research, Ltd.

Phone: 888.451.3937; 817.568.6725

Results disclosure agreements

  • Principal investigator is a sponsor employee The PI should hold confidential, and not disclose directly or indirectly to any third party onther than Contractors, the data arising out of the study.
  • Publication restrictions are in place

Restriction type: OTHER